The University of Chicago Header Logo

Connection

Urs C. Schmidt-Ott to Macular Degeneration

Back to Details
This is a "connection" page, showing publications Urs C. Schmidt-Ott has written about Macular Degeneration.
Urs C. Schmidt-Ott
Connection Strength
0.218
Macular Degeneration
  1. Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial. Lancet. 2024 Mar 23; 403(10432):1141-1152.
    View in: PubMed
    Score: 0.218
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.